Interní Med. 2010; 12(4): 200-204

Chronic pain, diagnostics and therapy

MUDr.Pavlína Nosková
Centrum léčby bolesti KARIM VFN a 1. LF UK Praha

Chronic pain (CHP) remains unresolved problem of present medicine. 40–60 % patients suffering with CHP do not regard pain release

sufficient. The decisive therapeutic approach is optimal differentiation assessment of pain according to its etiology. This point is necessary

for successful treatment. Opiate analgetics represent a choice regardless of certain historic reserved distance. Suitable analgetics

for long-term treatment are another crucial factor. Adverse events rising from favourite non-steroid analgetics use have to be minimised.

When pharmacotherapy, rehabilitation, psychotherapy had been depleted, new invasive analgetic methods are to be considered. Neuromodulationis

on the edge of todays development. Multidisciplinary access is emphasised in treatment effort.

Keywords: chronic pain, pain assessment, pain types, analgetics, adjuvant compounds, invasive approaches

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P. Chronic pain, diagnostics and therapy. Interní Med. 2010;12(4):200-204.
Download citation

References

  1. Rokyta R. Patofyziologie bolesti. Postgraduální medicína 2003; 5(1): 51-54.
  2. Doležal T, Hakl M, Kozák J, et al. Metodické pokyny pro farmakoterapii akutní a chronické nenádorové bolesti. SSLB 2006.
  3. Lauterburg BH. Analgesics and glutathione. Am.J.Ther. 2002; 9: 225-233. Go to original source... Go to PubMed...
  4. Kršiak M. Farmakoterapie bolestí zad. Bolest 2007; 10(1): 14.
  5. Kozák J. Medicína pro praxi 2009; 6(supp A): 15-24.
  6. Kršiak M. Pokroky ve farmakoterapii bolesti. Medicína pro praxi 2009; 6 (suppl. A): 6-14.
  7. Mečíř P. Neurologové se ptají. Neurologie pro praxi 2008; 9(2): 119.
  8. Doležal T, Hakl M, Kozák J, et al. Metodické pokyny pro farmakoterapii nádorové bolesti. SSLB 2006.
  9. Rokyta R, Kršiak M, Kozák J. Bolest. Praha: Tigis 2006.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.